Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio

References

• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
   PubMed Web of Science ®Google Scholar
• GBD 2015 Mortality and Causes of Death CollaboratorsGlobal, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet2016388100531459154427733281
   PubMed Web of Science ®Google Scholar
• GBD 2015 Mortality and Causes of Death CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet2016388100531545160227733282
   PubMed Web of Science ®Google Scholar
• GBD 2015 Mortality and Causes of Death CollaboratorsGlobal, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet Respir Med20175969170628822787
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulmon Dis2009420322319554195
   PubMedGoogle Scholar
• FlattetYGarinNSerratriceJPerrierAStirnemannJCarballoSDetermining prognosis in acute exacerbation of COPDInt J Chron Obstruct Pulmon Dis20171246747528203070
   PubMed Web of Science ®Google Scholar
• RocheNZureikMSoussanDNeukirchFPerrotinDUrgence BPCO (COPD Emergency) Scientific CommitteePredictors of outcomes in COPD exacerbation cases presenting to the emergency departmentEur Respir J200832495396118508819
   PubMed Web of Science ®Google Scholar
• AnzuetoAImpact of exacerbations on COPDEur Respir Rev20101911611311820956179
   PubMedGoogle Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• CelliBRDecramerMWedzichaJAAn official American Thoracic Society/European Respiratory Society statement: research questions in COPDEur Respir J201545487990525829431
   PubMed Web of Science ®Google Scholar
• CelliBRPredictors of mortality in COPDRespir Med2010104677377920417082
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• CoteCGPinto-PlataVKasprzykKDordellyLJCelliBRThe 6-min walk distance, peak oxygen uptake, and mortality in COPDChest200713261778178517925409
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
   PubMed Web of Science ®Google Scholar
• MartinezFJFosterGCurtisJLPredictors of mortality in patients with emphysema and severe airflow obstructionAm J Respir Crit Care Med2006173121326133416543549
   PubMed Web of Science ®Google Scholar
• NishimuraKIzumiTTsukinoMOgaTDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest200212151434144012006425
   PubMed Web of Science ®Google Scholar
• de-TorresJPMarinJMPinto-PlataVIs COPD a progressive disease? A long term bode cohort observationPLoS One2016114e015185627100872
   PubMed Web of Science ®Google Scholar
• CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
   PubMed Web of Science ®Google Scholar
• O’DonnellDEWebbKANederJALung hyperinflation in COPD: applying physiology to clinical practiceCOPD Res Pract2015114
   Google Scholar
• RamonMAFerrerJGimeno-SantosEInspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPDRespirology201621347648226714424
   PubMed Web of Science ®Google Scholar
• AlbuquerqueALNeryLEVillacaDSInspiratory fraction and exercise impairment in COPD patients GOLD stages II–IIIEur Respir J200628593994416870665
   PubMed Web of Science ®Google Scholar
• CebolleroPZambom-FerraresiFHernandezMHuetoJCascanteJAntonMMInspiratory fraction as a marker of skeletal muscle dysfunction in patients with COPDRev Port Pneumol (2006)20172313927553972
   PubMed Web of Science ®Google Scholar
• WedzichaJAMechanisms of chronic obstructive pulmonary disease exacerbationsAnn Am Thorac Soc201512Suppl 2S157S159
   Web of Science ®Google Scholar
• ZamanMMahmoodSAltayehALow inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbationAm J Med Sci2010339541141420375693
   PubMed Web of Science ®Google Scholar
• FrenchABalfeDMirochaJMFalkJAMosenifarZThe inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101305131226203237
   PubMed Web of Science ®Google Scholar
• TantucciCDonatiPNicosiaFInspiratory capacity predicts mortality in patients with chronic obstructive pulmonary diseaseRespir Med2008102461361918083020
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J Suppl19936Suppl 16540
   Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• CelliBRDecramerMLiuDMetzdorfNAsijeeGMTashkinDPDefining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT(R) trialRespir Res20161714827141828
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CatalunaJJCalleMSpanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phaseArch Bronconeumol201753632433528477954
   PubMed Web of Science ®Google Scholar